WuXi Biologics (OTCPK:WXIBF ... has agreed to sell the plant to Merck (NYSE:MRK) for around $500M, according to Reuters. In late December, WuXi Apptec (OTCPK:WUXIF) said it had agreed to sell ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

WuXi Biologics differentiates itself from other well-established global contract development and manufacturing organizations, with its "follow-and-win the molecule" and "global dual-sourcing ...

WuXi Biologics differentiates itself from other global well-established contract development and manufacturing organizations, with its “follow-and-win the molecule” and the “global dual ...

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost ...

January 6, 2025 China's WuXi Biologics to sell Irish vaccine facility ... April 11, 2024 Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion Japan's Fujifilm will invest ...

Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, March 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development ...

WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been included in the S&P Global Sustainability ...